Re
Reaction Biology
Malvern PAFounded 2001100 employees
Private CapbiotechPrivateOncology
Platform: Assay Services
Market Cap
N/A
All Drugs
2
Clinical Trials
6
Failed / Terminated
2
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| REA-6162 | REA-6162 | Preclinical | 2 | JAK2 | FTD | ||
| Lisoderotide | REA-3450 | Phase 3 | 4 | TNFα | FTDUrothelial Ca |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (6)